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ABSTRACT
Background and the purpose of the study: Vasopressin type 2 receptor (V2R), a G protein 
coupled receptor (GPCR), plays an important role in the regulation of renal antidiuretic function. 
The highly conserved DRH motif is essential for G protein signaling of V2R; however its role  
especially regarding the histidin residue is not fully understood.. 
Methods: Site directed mutagenesis was performed with replacements of the histidin to isoleucine 
by using nested polymerase chain reaction. ELISA was performed for receptor expression assay 
and the adenylyl cyclase activity assay was performed for functional characterization of DRI 
mutation on V2R signaling.
Results and major conclusion: The adenylyl cyclase activity assay in COS-7 cells showed 
no difference in the amount of cAMP production between the wild type and the mutant V2 
receptors. The V2 receptor expression was not changed in the presence of this mutation using 
ELISA assay. These results suggest that the role of histidin residue is not critical in the V2 
receptor function, however further mutagenesis studies are required to define the role of this 
motif in V2R function. 
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INTRODUCTION
Vasopressin type 2 receptor (V2R) is a rhodopsin-
like G protein coupled receptor (GPCR) that plays an 
important role in water homeostasis in physiological 
and pathological conditions (1). It is positively 
linked to the Gs protein and its second messenger 
is cAMP (2). A number of common receptor regions 
are involved in the signal transduction pathways of 
GPCRs (3). One of the highly conserved motifs is the 
triplet of amino acids; glutamic acid/aspartic acid–
arginine–tyrosine (DRY motif) which is located at the 
boundary between the third transmembrane region 
and the second intracellular loop (4). This segment 
of GPCRs has been shown to play an important 
role in cell surface delivery, internalization, ligand 
binding affinities, phosphorylation, desensitization 
and normal receptor function (5, 6). By forming 
intramolecular interactions, DRY motif has a pivotal 
role in the regulation of GPCR conformations in 
signaling  and  intracellular  trafficking  (4).  Some 
mutations in this motif result in receptors  with 
impaired signal transduction which are responsible 
for certain human diseases (7).
Congenital nephrogenic diabetes insipidus (NDI) is 
a rare disease with impairment of water reabsorption 
in renal collecting ducts and mutations in the V2R (8, 
9). In V2R, the DRY motif is a DRH and one of the 
first-characterized mutations in NDI was R137H in 
this motif with inability of ligand-bound receptor to 
activate G proteins (9, 10). Despite extensive studies 
in other receptors, there are only limited findings 
about mutations in aspartate and arginine residues 
in V2R (11-13). Since there is no data available on 
the role of histidin residue in DRH motif in V2R, it 
was decided to use site directed mutagenesis in this 
region as DRI to gain some new insights into the 
receptor-function relationship. 
MATERIAL AND METHODS
Plasmids and constructs
cDNA of the wild type V2R in pcDNA3 vector 
obtained from Dr. Birnbaumer’s laboratory (8) 
was used as the template for the construction of 
the mutant V2R. A pair of primers was designed 
for DRI (aspartate-arginine-isoleucine) mutant by 
using WDNASIS26  program (Hitachi Software 
Engineering Co., Tokyo, Japan). Two pairs of outer 
and inner sense and antisense primers in cDNA 
of V2R and pcDNA3 vector were also designed. 
Mutation of DRH motif in vasopressin type 2 receptor
A schematic presentation of pcDNA3 plasmid 
containing wild type V2R and the location of the 
above mentioned primers is shown in figure 1.
The  primer  sequences  were  as  follows:  sense         
(5’-cgctggaccggatccgtgccatc-3’) and anti-sense 
(5’-gatggcacggatccggtccagcg-3’) for DRI mutant, 
sense (5’-cccagcaacagcagccag-3’) and anti-sense 
(5’-tcatcctcacagtcttgg-3’) for inner in V2R, sense 
(5’-ccaccacttccgctgtgc-3’) and anti-sense (5’-
acccaacagctcctcacg-3’) for outer in V2R, sense 
(5’-gtggatagcggtttgact-3’) and anti-sense (5’-
ggtcaaggaaggcacgg-3’) for inner in pcDNA3 and   
sense (5’-tgggtggactatttacgg-3’) and anti-sense (5’-
gttctttccgcctcaga-3’) for outer in pcDNA3. 
Nested polymerase chain reaction (PCR) was used 
for the synthesis of the mutant V2 receptor insert. The 
first PCR was performed using 50 ng cDNA of V2R 
(as template), 5 μl 10X PCR buffer containing 2 mM 
MgCl2 (Biotools, B & M Labs, Madrid, Spane), 0.5 
mM dNTP (Eurobio Laboratories, France), 5 U Taq 
DNA polymerase (Biotools), 2.5 µM of each sense 
and anti-sense of DRI with outer primers in V2R in 
2 steps (total volume of 50 µl). The PCR conditions 
were set as follows: 1 cycle (94°C for 5 min), 33 cycles 
(94oC for 1 min, 55oC for 2 min, 72°C for 2 min), and 
1 cycle (72°C for 20 min) in a Thermostable DNA 
Termocycler (Bio-Rad Laboratories, California, 
USA). After electrophoresis on 0.7% agarose gel 
(Roche, Germany) and determination of the size 
of the obtained DNA, the products of the first PCR 
were used as the template for the second (nested) 
PCR with sense and anti-sense of inner primers in 
V2R (14). 
The  PCR  products  were  confirmed  by  staining 
of the agarose gel with ethidium bromide using a 
UV transilluminator, and the obtained DNA bands 
were detected. The products containing the desired 
mutation were digested by BamHI, EcoRI and XbaI 
restriction enzymes (Fermentas). DNA was extracted 
from the agarose gel using QIAquic kit (Qiagen, 
Valencia, CA, USA). The DRI insert was ligated to 
pcDNA3 vector with a molar ratio of 3/1 (insert to 
vector). Transformation was performed using E.coli 
HB101 competent cells (Cinnagen, Tehran, Iran) 
with heat shock method and plasmid were prepared 
by alkaline lysis procedure using plasmid preparation 
kit from Bio-Rad, USA (15, 16).
Cell culture and transfection
COS-7 cells (Pasteur Institute, Tehran, Iran) were 
grown  in  DMEM  (Dulbecco’s  modified  eagle 
medium), with 10% FBS (fetal bovine serum) 
(Gibco, BRL Life Technologies, Glasgow, Scotland), 
penicillin (50 U/ml), and streptomycin (50 µg/ml) 
(Sigma, St. Louis, USA) in an incubator (5% CO2) 
at 37°C. For transient expression, cells were placed 
at a density of 5×105 cells per well in a 24-well plate 
and  transfection  was  performed  using  modified 
Luthman and Magnusson method (8). Briefly, each 
plate was treated with 800 µl of Hanks buffer, pH of 
7 (Sigma), containing 3 µg plasmid DNA of mutant 
or wild type V2R (0.5-2 μg) mixed with 0.5 mg/ml 
diethylaminoethyl-dextran (Sigma). The cells were 
incubated for 20 min at room temperature and then 
treated with 100 µM Chloroquine (Sigma) in DMEM 
containing 2% FBS. After 3 hrs incubation at 37°C, 
the cells were exposed to 10% dimethyl sulfoxide 
(Sigma) in Hanks buffer for 2 min, rinsed with 
DMEM, and treated with normal growth medium at 
37°C. 
ELISA
COS-7 cells were transiently transfected with the 
wild type or mutant V2R (the receptor containing 
the HA epitope at the C or N terminus) (11). For 
receptor expression assay, ELISA was performed 
using the 12CA5 monoclonal antibody (Sigma) 
against  N-terminal  epitope  of V2R  (8).  Briefly, 
following 24 hrs transfection, cells were placed at 
a density of 3-5×105 cells per well in a 96-well 
plate. Then the medium was removed and 1 µg 
of 12CA5 of antibody/100 µl solution was added. 
After one hour incubation at 37°C, the cells were 
fixed with 4% formaldehyde in PBS. Wells were 
incubated with a 1:2500 dilution of horseradish 
peroxidase-conjugated anti-mouse IgG in PBS 
(Sigma) at 37°C for 2 hrs. The enzymatic reaction 
was induced by H2O2 and O-phenylenediamine (2.5 
mM) (Sigma) and then the reaction was stopped 
by the addition of 3M HCl. The optical density 
was measured at 492 nm in a microplate reader 
(STAT  FAX,  USA).  Transfected  cells  without 
DNA and cells without transfection were used as 
the negative controls.
Adenylyl cyclase activity assay
Forty eight hrs after transfection, the cells were 
exposed to 100 nM vasopressin (Sigma), 2mM 
isobutylmethylxanthine  (Sigma)  or  100  μM 
forskolin (Sigma) for 20 min at 37°C (8, 10). After 
rinsing with Hanks buffer and lysis by 0.1M HCl, the 
cAMP was measured using a cAMP (direct) enzyme 
immunoassay kit (Assay Designs, Ann Arbor, 
USA). The procedure was performed according to 
the manufacture’s instruction by using a polyclonal 
antibody against cAMP. After simultaneous 
incubation at room temperature, the excess reagents 
were washed away and substrate was added. After 
a short incubation time the enzyme reaction was 
stopped and the generated yellow color was read on 
a microplate reader at 405 nm.
Statistical analyses
Statistical comparisons were performed by Student’s 
t-test or one-way analysis of variance (ANOVA) 
followed by Dunnett test. The data are presented 
as the mean ± SEM; p value <0.05 was considered 
statistically significant.287
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RESULTS AND DSCUSSION
The products of the first and second (nested) PCR of 
DRI mutant are shown in figure 2. Since there was a 
restriction site for BamH I enzyme at the DRH motif 
of V2 receptor cDNA, the nested PCR product was 
digested by this enzyme to confirm that the primer 
design and PCR process are correct (Fig 3).
For vector preparation, pcDNA3 containing the wild 
type V2R was digested by EcoRI and XbaI enzymes 
which removed the V2 receptor DNA (1200 bp) out 
of the pcDNA3 plasmid (5400 bp) (Fig 4).
Following ligation of DRI insert to pcDNA3 vector 
and transformation to HB101 cells, colonies of 
bacteria were observed after overnight culture on 
an agar plate. The clones that were supposed to 
have uncut pcDNA3 containing DRI mutant were 
used for plasmid preparation. These plasmids were 
digested by BamHI enzyme and the presence of a 
500 bp band indicated that these plasmids were 
recombinants. These plasmids were also digested by 
EcoRI and XbaI enzymes and a 1200 bp band of V2 
receptor cDNA was obtained.                  
The adenylyl cyclase activity assay was performed 
for functional characterization of DRI mutation on 
V2R signaling. The standard curve was generated 
using serial dilutions of standard solutions. The 
14
Fig 7. The effects of the mutation of the His residue in the DRH motif on V2 receptor expression 
in COS-7 cells by ELISA assay.  The cells were transfected without any plasmid (CTL) or with a 
plasmid containing the wild type cDNA of V2R (WT) or containing DRI mutant cDNA of V2R 
(DRI). Cells were placed at a density of 5 ×10
5 cells per well in a 96-well plate and the amount 
of DNA for each plasmids was 1000 ng. Data represent the optical density (OD) as mean ± SEM 
(n=20), *P <0.05 vs. control. 
Figures: 
Fig 1: 
Fig 2a, b: 
Figure 1. Schematic presentation of pcDNA3 plasmid containing 
wild type V2R sequence (shown in bold). Primers used for the 
PCR amplification of this sequence and creation of DRI mutation 
are also disclosed. Three pair of primers (outer, inner and DRI) 
were utilized in this study.
15
 Fig 3: 
Fig 4:
Figure 2. First (a) and nested (b) PCR of DRI mutant at V2 
receptor. Products of PCR were electrophoresed on 0.7% agarose 
gel. In the first PCR by using sense primer of DRI and anti-sense 
of outer primer in pcDNA3 (step 1) as well as anti-sense primer 
of DRI and sense of outer primer in pcDNA3 (step 2), a sharp and 
dense band of 1000 bp was produced. In the nested PCR, by using 
the first PCR products and sense and anti-sense of inner primer in 
pcDNA3, a band of 1500 bp was detected. M: molecular weight 
marker, 250 bp unit.
15
 Fig 3: 
Fig 4:
Figure 3. Digestion of the nested PCR of DRI mutant by BamHI. 
Products of digestion were electrophoresed on 0.7% agarose 
gel. A band of 500 bp was obtained, indicating the presence of 
mutation in the PCR product. M: molecular weight marker, 250 
bp unit.
16
Fig 5:
Figure 4. Digestion of pcDNA3 plasmid containing wild type 
V2R  by  XbaI-EcoRI  enzymes.  Products  of  digestion  were 
electrophoresed on 0.7% agarose gel. The band of V2R (1200 
bp) was digested out of the pcDNA3 plasmid. M: molecular 
weight marker, 250 bp unit.289 Mir Mohammad Sadeghi et al / DARU 2010 18 (4) 286-291
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Mutation of DRH motif in vasopressin type 2 receptor
amount of cAMP was inversely related to optical 
absorbance. The cAMP production measured in 
COS-7 cells transfected with the wild type and 
mutant V2R are shown in figures 5 and 6. When 
compared to the untransfected cells, there was a 
significant forskolin mediated production of cAMP 
in cells transfected with the wild type receptor 
(p<0.05) (Fig 5). On the other hand vasopressin 
increased the intracellular production of cAMP 
in cells transfected with the wild type and mutant 
receptors,  no  significant  difference  was  observed 
between these groups (Fig 6).  
The results of ELISA for receptor expression assay 
are shown in figure 7. No significant difference was 
observed in receptor expression between the wild 
type and mutant receptors. 
DRY motif seems to be an important determinant 
in the signal transduction of GPCRs (1). However, 
various site-directed mutagenesis in this region have 
not revealed a universal role for this motif and its role 
in GPCR activation and signaling may be different 
in various receptors (7). To further study the role of 
this motif in the V2 receptor expression and function, 
DRI mutant DNA was created in V2R.
In this study, the DRI mutation was cloned into 
the pcDNA3 vector and functional assays showed 
no difference in the amount of cAMP production 
between the wild type and the mutant V2 receptors. 
For receptor expression, the ELISA method was 
employed which allows more accurate quantification 
of receptors at the cell surface in comparison with 
other techniques (7). The V2 receptor expression 
also did not change in the presence of this mutation. 
These results suggest that the role of histidin residue 
may be not critical in the V2 receptor function.
While different site-directed mutations have been 
studied in GPCRs, much less is known about the role 
of the DRH motif in V2R function. The results of 
V2R studies have shown that mutation of aspartate 
residue (D136A) in DRH motif increased the cAMP 
production by 5 folds (11).
Mutations in arginine residue of the V2R may 
result in decreased expression and loss of function 
and to produce a constitutively desensitized 
phenotype (12). 
Figure 5. cAMP concentration (pmol/ml) in COS-7 cells. The 
cells were transfected without plasmid in the absence of forskolin 
treatment (CTL) or with a plasmid containing wild type cDNA of 
V2R in the presence of forskolin (FORS) treatment (100 μM) for 
20 min at 37°C. Cells were placed at a density of 5×105 cells per 
well in a 24-well plate and amount of DNA of plasmids was 1000 
ng. Data represent the mean ± SEM (n=10), *P <0.05.
Figure 6. The effects of the mutation of the His residue in the 
DRH motif of V2 receptor on cAMP concentration (pmol/ml) 
in COS-7 cells. The cells were transfected with a plasmid 
containing the wild type cDNA of V2R (WT) or containing DRI 
mutant cDNA of V2R (DRI). Both groups were treated with 
methylxanthine (2 mM) and vasopressin (100 nM) for 20 min at 
37°C. Cells were placed at a density of 5×105 cells per well in a 
24-well plate and DNA amount for each plasmid was 1000 ng. 
Data represent the mean ± SEM (n=20).
Figure 7. The effects of the mutation of the His residue in the 
DRH motif on V2 receptor expression in COS-7 cells by ELISA 
assay.  The cells were transfected without any plasmid (CTL) or 
with a plasmid containing the wild type cDNA of V2R (WT) or 
containing DRI mutant cDNA of V2R (DRI). Cells were placed 
at a density of 5 ×105  per well in a 96-well plate and the amount 
of DNA for each plasmids was 1000 ng. Data represent the optical 
density (OD) as mean ± SEM (n=20), *P <0.05 vs. control.
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The tyrosine residue has not been extensively 
studied among the DRY sequence. Some studies 
have reported that variation of the Tyr residue in 
the DRY motif may be functionally tolerated (17). 
However, since the functional relevance of the 
residues within DRY motif seems to be receptor and 
context specific (18), further studies are required 
in each specific receptor to determine the role of 
individual residue. 
In some receptors such as CCR3 chemokine receptor 
and rat melanin-concentrating hormone receptor 
1, tyrosine mutation in DRY motif has resulted 
in poorly expressed and non-functional receptors 
(3, 19). Replacements of tyrosine (Y150A) in 
vasopressin V1a receptor has led to decrease in 
signal  transduction with little effect on ligand 
binding, signaling, and receptor internalization (7). 
Although the functional role of tyrosine residue in 
DRY motif is unclear, it seems that intramolecular 
contact of Tyr with Asp and its integrity is important 
for  efficient  receptor  folding.  Moreover  although 
the tyrosine residue does not participate directly 
in  receptor  signaling,  it  may  influence  maximal 
responses regarding receptor signaling (7). 
In summary, aspartate-arginine-tyrosine triple 
residues play an important role in the signal 
transduction pathways  of GPCRS, but may not 
have the same function in all receptors. Regarding 
V2 receptor it seems that the histidin residue is not 
critical by itself and its mutation did not affect the V2 
receptor function and expression. However further 
studies are required to look into various mutations of 
these residues to shed some more light on their exact 
role in the V2 receptor function.
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